SARS-CoV-2 variants of concern partially escape humoral but not T cell responses in COVID-19 convalescent donors and vaccine recipients
D Geers, MC Shamier, S Bogers, G den Hartog… - Science …, 2021 - science.org
The emergence of SARS-CoV-2 variants harboring mutations in the spike (S) protein has
raised concern about potential immune escape. Here, we studied humoral and cellular …
raised concern about potential immune escape. Here, we studied humoral and cellular …
Divergent SARS-CoV-2 Omicron–reactive T and B cell responses in COVID-19 vaccine recipients
CH GeurtsvanKessel, D Geers, KS Schmitz… - Science …, 2022 - science.org
The severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV-2) Omicron
variant is spreading rapidly, even in vaccinated individuals, raising concerns about immune …
variant is spreading rapidly, even in vaccinated individuals, raising concerns about immune …
Immunogenicity and reactogenicity of vaccine boosters after Ad26. COV2. S priming
…, DF Postma, LG Visser, D Geers… - … England Journal of …, 2022 - Mass Medical Soc
Background The Ad26.COV2.S vaccine, which was approved as a single-shot immunization
regimen, has been shown to be effective against severe coronavirus disease 2019. …
regimen, has been shown to be effective against severe coronavirus disease 2019. …
The RECOVAC immune-response study: the immunogenicity, tolerability, and safety of COVID-19 vaccination in patients with chronic kidney disease, on dialysis, or …
…, DA Diavatopoulos, SC Frölke, D Geers… - …, 2022 - journals.lww.com
Background. In kidney patients COVID-19 is associated with severely increased morbidity
and mortality. A comprehensive comparison of the immunogenicity, tolerability, and safety of …
and mortality. A comprehensive comparison of the immunogenicity, tolerability, and safety of …
Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine …
…, SRK Malahe, P Vart, D Geers… - The Lancet Infectious …, 2023 - thelancet.com
Background An urgent need exists to improve the suboptimal COVID-19 vaccine response
in kidney transplant recipients (KTRs). We aimed to compare three alternative strategies with …
in kidney transplant recipients (KTRs). We aimed to compare three alternative strategies with …
Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study
KS Hensley, MJ Jongkees, D Geers… - PLoS …, 2022 - journals.plos.org
Background Vaccines can be less immunogenic in people living with HIV (PLWH), but for
SARS-CoV-2 vaccinations this is unknown. In this study we set out to investigate, for the …
SARS-CoV-2 vaccinations this is unknown. In this study we set out to investigate, for the …
Immunogenicity of bivalent omicron (BA. 1) booster vaccination after different priming regimens in health-care workers in the Netherlands (SWITCH ON): results from …
NH Tan, D Geers, RSG Sablerolles… - The Lancet Infectious …, 2023 - thelancet.com
Background Bivalent mRNA-based COVID-19 vaccines encoding the ancestral and omicron
spike (S) protein were developed as a countermeasure against antigenically distinct SARS-…
spike (S) protein were developed as a countermeasure against antigenically distinct SARS-…
From A to m6A: The Emerging Viral Epitranscriptome
B Baquero-Perez, D Geers, J Díez - Viruses, 2021 - mdpi.com
There are over 100 different chemical RNA modifications, collectively known as the
epitranscriptome. N 6 -methyladenosine (m 6 A) is the most commonly found internal RNA …
epitranscriptome. N 6 -methyladenosine (m 6 A) is the most commonly found internal RNA …
[HTML][HTML] Immunogenicity of the mRNA-1273 COVID-19 vaccine in adult patients with inborn errors of immunity
…, F de Wilt, S Bogers, L Gommers, D Geers… - Journal of Allergy and …, 2022 - Elsevier
Background Patients with inborn errors of immunity (IEI) are at increased risk of severe
coronavirus disease-2019 (COVID-19). Effective vaccination against COVID-19 is therefore of …
coronavirus disease-2019 (COVID-19). Effective vaccination against COVID-19 is therefore of …
Immunogenicity of an additional mRNA-1273 SARS-CoV-2 vaccination in people with HIV with hyporesponse after primary vaccination
MJ Jongkees, D Geers, KS Hensley… - The Journal of …, 2023 - academic.oup.com
Background The COVIH study is a prospective coronavirus disease 2019 (COVID-19)
vaccination study in 1154 people with HIV (PWH), of whom 14% showed reduced antibody levels …
vaccination study in 1154 people with HIV (PWH), of whom 14% showed reduced antibody levels …